A statement from the NSW Department of Industry said that its figures showed that up to 50% of people who had chronic medical conditions failed to regularly take the medications they had been prescribed.
The money given to Perx was a Minimum Viable Grant and the company is now testing its technology using a $100,000 Building Partnerships grant.
Perx co-founder Hugo Rourke said according to a World Health Organisation estimate, 1 in 3 people in OECD countries had a chronic condition and up to half did not take medication as prescribed.
“Our app monitors a user's medication regime and gives them a chance to win a reward every time they stick to their schedule, encouraging them to develop positive habits."
The NSW DoI statement quoted one diabetes sufferer as saying the Perx app had helped him to manage his health issues.
“The app has helped me manage my medication in a big way. I spread the word to friends and relatives and some of them have taken it on as well,” said Artarmon retiree Lindsay Alexander.
“As a bonus, when I take my medication on cue I get rewards like cinema tickets, fuel cards or shopping vouchers which is a good incentive."
Another user of the app, Coniston resident Therese Francis, said it had made a big difference as she needed to take a number of different medications, including for cholesterol and painkillers, at different times.
“Before the app came along it was easy to forget to take my medication or I could take them later than I should. It has most definitely helped my health. I recommend this app for anyone of any age who needs to take medication regularly," she said."
NSW Deputy Premier and Minister for Small Business John Barilaro said Jobs for NSW funding had helped Perx to develop its easy-to-use mobile app alongside sophisticated rewards software.
“Jobs for NSW is now helping Perx in the next stage with a grant to help with clinical and commercial validation, working with the University of Sydney’s Boden Institute and with the Sydney Local Health District by assisting diabetes and cardiovascular outpatients,” he said.